Molecular genetics of urothelial cancer of the bladder
نویسنده
چکیده
s not related to Theses 10. Bagheri F, Pusztai Cs, Szántó Á, Fábos Z, Beöthe T, Jávorházy A, Bányai D, Farkas L: Laparoscopic nehphron sparing surgery: impact of resected volume on renal function. European Urology Meeting 3:(10) p. 103. (2008) 11. Székely J, Bagheri F, Villányi K, Pusztai Cs, Szántó Á, Beöthe T, Farkas L: Percutaneous nephropexy with U-tube nephrostomy:long-term followup as an alternative technique for treatment of symptomatic nephroptosis. Urology 68:(5/A) p. 227. (2006). Citation: 0 IF: 2.130 12. Pusztai Cs, Farkas L, Villányi K, Beöthe T: Bilateralis csírasejtes heredaganaok klinikánk 25 éves anyagában. Magyar Urológia 18:(3) p. 180. (2006) 13. J G Székely, L Farkas, K Villányi, Cs Pusztai, T Z Beöthe: Possibilities to Improve the Effectivity of Endopyelotomy. Journal of Endourology 12: p. 132. (1998). Poster presentations related to Theses 14. Beöthe T., Szakács O., Orient A., Nagy A., Somogyi L., Farkas L., Kovács Gy.: A húgyhólyagtumor recidívák individuális, nem-invazív diagnózisa mikroszatellita vizsgálattal. Magyar Urológusok Társaságának XII. Kongresszusa, Szeged 2003. Oral presentations related to Theses 15. Beöthe T., Szakács O., Kovács Gy., Farkas L.:A 11-es kromoszóma rövid karjának részletes mikroszatellita vizsgálata. Magyar Urológusok Társaságának XIII. Kongresszusa, Siófok 2006. 16. T. Beöthe, F. Sükösd, Gy. Kovács, L. Farkas: Possibilities of Molecular-Genetic Techniques in the Uro-oncological Diagnostic, Fiatal Magyar Urológusok III. Angol nyelvű fóruma, Debrecen 2002. Oral presentations not related to Theses 17. T. Beöthe, J. Székely, L. Farkas: Difficulties in Diagnosis of Kidney’s Chondrosarcoma, Fiatal Magyar Urológusok II. Angol Nyelvű Fóruma, Debrecen, 2001. 18. Dr. Beöthe T., Dr. Pusztai Cs., Dr. Székely J., Dr. Farkas L.: Urethrosacralis fistula minimalinvazív ellátása. Közép Európai Urológus Társaság (CEAU) II. Kongresszusa, Budapest, 2000. 19. Dr. Beöthe T., Dr. Pusztai Cs., Dr. Székely J., Dr. Farkas L.: Urethrosacralis fistula minimalinvazív ellátása. Bajai Kórház Urológiai Osztály Ünnepi Tudományos Ülése, Baja 2000.
منابع مشابه
Dysregulated Expression of Long Intergenic Non-coding RNAs (LincRNAs) in Urothelial Bladder Carcinoma
Long intergenic non-coding RNA (lincRNA) has been introduced as key regulators of diverse biological processes, including transcription, chromatin organization, cell growth and tumorigenesis. With regard to the potential role of lincRNAs in cancer development, one may postulate that differential expression of lincRNAs could be employed as a tool in cancer diagnosis, prognosis, and targeted ther...
متن کاملEvaluation of MicroRNA-99a and MicroRNA-205 Expression Levels in Bladder Cancer
Bladder cancer is the second most common cancer in the genitourinary tract, showing often recurrence and progresse into invasive states. Epigenetic changes, such as microRNA alteration are involved in bladder cancer tumorigenesis through a variety of signaling pathways. The epigenetic state depends on geographic and lifestyle conditions. The aim of this study was to investigate the expression l...
متن کاملMicroRNAs as biomarkers associated with bladder cancer
Bladder cancer is the fifth most common cancer with significant morbidity and mortality. Recently, numerous studies demonstrated that microRNAs are emerging as diagnostic biomarkers for bladder cancer. Specific miRNA profiles have been identified for several samples from patients with bladder cancer. MicroRNAs are noncoding RNA molecules of approximately 23 nucleotides that play important roles...
متن کاملEvaluating the Expression of Oct4 as a Prognostic Tumor Marker in Bladder Cancer
Objective(s)The key transcriptional regulator Oct4 is one of the self-renewal and differentiation-related factors in cancer stem cells, where it maintains "stemness" state. Cancer stem cells have been identified in a variety of solid malignancies. They are a small population of tumor cells with stem cell characteristics, which are a likely cause of relapse in cancer patients. Due to high incide...
متن کاملHigh-Grade Urothelial Carcinoma of Bladder Transforming to Micropapillary Variant on Follow-Up
Micropapillary variant of urothelial carcinoma (UC) of the bladder is an aggressive tumour, comprising 0.6-6% of all UC. It generally presents with high-grade and stage, and has been reported as having a worse prognosis when compared to traditional UC. We report the case of a 58-year-old man who presented with macroscopic haematuria. The patient was diagnosed with high-grade urothelial carcinom...
متن کاملگزارش یک مورد سرطان اوروتلیال پلاسماسیتوئید مثانه
Bladder cancer most commonly exists as an epithelial tumor in which around 90% of cases are transitional cell carcinoma (TCC) with a papillary appearance. The world health organization (WHO) classification defines new histological and molecular variants of urothelial carcinoma in 2004. One of them is plasmacytoid urothelial carcinoma (PUC). Less than 100 cases have been reported in the literatu...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2012